2018 Radioactive I-125 Seed Localization of Non-Palpable Breast Lesions at Florida Hospital


Date
Tuesday, August 14, 2018, 6:30 AM - Saturday, November 30, 2019, 6:30 PM, Orlando, Orlando, FL

Overview
Radioactive seed localization has improved our rates of negative margins of excision. First, the entry site of the wire is often not at the ideal location for incision by the surgeon at the time of operation. This may lead to additional unnecessary dissection and suboptimal cosmetic results. In addition, the wire must be placed the day of operation, necessitating the coordination of radiology and operative schedules and eliminating the possibility of performing a wire-localized procedure as the first operation of the morning. The most important disadvantage, however, is the inaccuracy of localizing the target lesion transcutaneously and during dissection. The surgeon must estimate the ideal route to the lesion and the amount of tissue to be excised. This results in high rates of reoperations for tissue margins involved by carcinoma.

Objectives

This module is designed to assist the viewer in:
  1. Reducing the rates of intraoperative re-excision and re-operation for positive margins
  2. Recognizing that the patient has a five-day window in having the I-125 seed removed versus having the wire placed the day of the operation, necessitating the coordination of radiology and operative schedules.
  3. Eliminating the possibility of performing a wire-localized procedure as the first operation of the morning.

Registration

COST:  Complimentary



Accreditation

Florida Hospital is accredited by the Florida Medical Association (FMA) to provide continuing medical education for physicians.  Florida Hospital designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.

Physicians should only claim the credit commensurate with the extent of their participation in the activity.


The authors, planners and CPD Committee members involved in this activity have no financial relationships with any proprietary entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients.